Section I and II Templates Although prior consultations have taken place on the proposed format and content of Sections I and II of the PM, there remain two areas within these sections which require additional input.
Identifying these two areas of the PM in particular does not, however, preclude comments and discussion on other components of Sections I and II. The two areas in question are: the Adverse Reactions component (Section I); and the Clinical Trials component (Section II).